Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Scudla

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Onkologie|July 14, 2004
Second autologous transplantation for multiple myeloma patients relapsing after the first autograft -- a pilot study for the evaluation of experimental maintenance therapies. Report of the prospective non-randomized pilot study of the Czech Myeloma GroupA Krivanová, R Hájek, M Krejcí, et al.
Bone Marrow Transplantation|October 16, 2007
High-dose chemotherapy followed by autologous stem cell transplantation changes prognosis of IgD multiple myelomaV Maisnar, R Hájek, V Scudla, et al.
Vnitrni Lekarstvi|January 8, 2008
[Recommendations for early identification of damage to the skeleton by malignant processes, and for early diagnosis of multiple myeloma]Z Adam, J Bednarík, J Neubauer, et al.
Neoplasma|December 15, 2006
International Staging System required standardization of biochemical laboratory testing in multiple myelomaM Tichý, V Maisnar, V Palicka, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 13, 2011
Low molecular weight heparins for thromboprophylaxis during induction chemotherapy in patients with multiple myelomaP Kessler, L Pour, E Gregora, et al.
Vnitrni Lekarstvi|September 28, 1998
[Treatment of multiple myeloma with high-dose chemotherapy and transplantation of autologous hematopoietic stem cells and subsequent maintenance therapy with interferon alfa-2b or interferon alfa 2b and dexamethasone. Report of the ongoing study of the "4W" Czech Myeloma Group]Z Adam, M Krejcí, J Bacovský, et al.
Vnitrni Lekarstvi|April 24, 2002
[Quality of life and tolerance of maintenance therapy in patients with multiple myeloma]Z Adam, L Pour, A Svobodník, et al.
Vnitrni Lekarstvi|November 12, 2002
[Therapeutic results and changes in prognosis in patients with multiple myeloma in central and northern Moravia over the past 40 years]V Scudla, J Bacovský, K Indrák, et al.
Vnitrni Lekarstvi|November 6, 2001
[Autologous transplantation of peripheral hematopoietic cells and subsequent maintenance therapy with interferon alpha or interferon alpha and dexamethasone in patients with multiple myeloma--results from the 4W randomized clinical trial of the Czech Myeloma Group]M Krejcí, R Hájek, V Scudla, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Onkologie|July 14, 2004
Second autologous transplantation for multiple myeloma patients relapsing after the first autograft -- a pilot study for the evaluation of experimental maintenance therapies. Report of the prospective non-randomized pilot study of the Czech Myeloma GroupA Krivanová, R Hájek, M Krejcí, et al.
Bone Marrow Transplantation|October 16, 2007
High-dose chemotherapy followed by autologous stem cell transplantation changes prognosis of IgD multiple myelomaV Maisnar, R Hájek, V Scudla, et al.
Vnitrni Lekarstvi|January 8, 2008
[Recommendations for early identification of damage to the skeleton by malignant processes, and for early diagnosis of multiple myeloma]Z Adam, J Bednarík, J Neubauer, et al.
Neoplasma|December 15, 2006
International Staging System required standardization of biochemical laboratory testing in multiple myelomaM Tichý, V Maisnar, V Palicka, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 13, 2011
Low molecular weight heparins for thromboprophylaxis during induction chemotherapy in patients with multiple myelomaP Kessler, L Pour, E Gregora, et al.
Vnitrni Lekarstvi|September 28, 1998
[Treatment of multiple myeloma with high-dose chemotherapy and transplantation of autologous hematopoietic stem cells and subsequent maintenance therapy with interferon alfa-2b or interferon alfa 2b and dexamethasone. Report of the ongoing study of the "4W" Czech Myeloma Group]Z Adam, M Krejcí, J Bacovský, et al.
Vnitrni Lekarstvi|April 24, 2002
[Quality of life and tolerance of maintenance therapy in patients with multiple myeloma]Z Adam, L Pour, A Svobodník, et al.
Vnitrni Lekarstvi|November 12, 2002
[Therapeutic results and changes in prognosis in patients with multiple myeloma in central and northern Moravia over the past 40 years]V Scudla, J Bacovský, K Indrák, et al.
Vnitrni Lekarstvi|November 6, 2001
[Autologous transplantation of peripheral hematopoietic cells and subsequent maintenance therapy with interferon alpha or interferon alpha and dexamethasone in patients with multiple myeloma--results from the 4W randomized clinical trial of the Czech Myeloma Group]M Krejcí, R Hájek, V Scudla, et al.
Pageof 8